Our results from RT-qPCR showed that mRNA expressions of the IBA1 (Fig. 3A, P < 0.01) and GFAP (Fig. 4A, P < 0.01) in the AD-MSCs group were significantly lower than those in the TBI group. This evidence concerns the gene GFAP and Alzheimer disease.